Human Gene TherapyVol. 4, No. 5 Special FeatureThe Safety of Retroviral VectorsKurt C. Gunter, Arifa S. Khan, and Philip D. NoguchiKurt C. GunterSearch for more papers by this author, Arifa S. KhanSearch for more papers by this author, and Philip D. NoguchiAddress reprint requests to: Dr. Philip D. Noguchi, Division of Cellular and Gene Therapies, Office of Therapeutics Research and Review, Center For Biologics Evaluation and Research, 1401 Rockville Pike, Rockville, MD 20852-1448Search for more papers by this authorPublished Online:19 Mar 2008https://doi.org/10.1089/hum.1993.4.5-643AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byTumor-specific Expression of MicroRNA-26a Suppresses Human Hepatocellular Carcinoma Growth via Cyclin-dependent and -independent PathwaysMolecular Therapy, Vol. 19, No. 8Synthesis, characterization, and biomedical applications of core–shell-type stimuli-responsive nanogels – Nanogel composed of poly[2-(N,N-diethylamino)ethyl methacrylate] core and PEG tethered chainsReactive and Functional Polymers, Vol. 67, No. 11pH-Responsive PEGylated nanogels as targetable and low invasive endosomolytic agents to induce the enhanced transfection efficiency of nonviral gene vectors28 February 2007 | Colloid and Polymer Science, Vol. 285, No. 9In vivo expansion of two distinct dendritic cells in mouse livers and its impact on liver immune regulation1 January 2006 | Liver Transplantation, Vol. 12, No. 12Poly(propylacrylic acid)-mediated serum stabilization of cationic lipoplexes2 April 2012 | Journal of Biomaterials Science, Polymer Edition, Vol. 16, No. 2Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA18 August 2003 | Gene Therapy, Vol. 10, No. 19Gene therapy: theoretical and bioethical conceptsArchives of Medical Research, Vol. 34, No. 4Gene transfer in higher animals: theoretical considerations and key conceptsJournal of Biotechnology, Vol. 99, No. 1Electric gene transfer to the liver following systemic administration of plasmid DNA25 July 2002 | Gene Therapy, Vol. 9, No. 16Biliary Administration of Naked DNA Encoding Fas–Fc Protein Prevents Acute Liver Failure in Mice21 December 2004 | Human Gene Therapy, Vol. 13, No. 8Production of Transgenic Nonhuman PrimatesNoninfectious Gene Transfer and Expression Systems for Cancer Gene TherapyImproving plasmid DNA-mediated liver gene transfer by prolonging its retention in the hepatic vasculature1 January 2001 | The Journal of Gene Medicine, Vol. 3, No. 6Optimization of transcriptional regulatory elements for constructing plasmid vectorsGene, Vol. 272, No. 1-2Supplemental Guidance on Testing for Replication-Competent Retrovirus in Retroviral Vector-Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors6 July 2004 | Human Gene Therapy, Vol. 12, No. 3Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA9 August 1999 | Gene Therapy, Vol. 6, No. 7Safe, Efficient Production of Retroviral VectorsA Controlled, Phase 1 Clinical Trial to Evaluate the Safety and Effects in HIV-1 Infected Humans of Autologous Lymphocytes Transduced with a Ribozyme that Cleaves HIV-1 RNA. University of California San Diego, La Jolla, California20 March 2008 | Human Gene Therapy, Vol. 9, No. 16Genetic immunotherapy for cancerSeminars in Veterinary Medicine and Surgery: Small Animal, Vol. 12, No. 3Protection of Primary Human T Cells from HIV Infection by Trev: A Transdominant Fusion Gene20 March 2008 | Human Gene Therapy, Vol. 8, No. 7Use of Donor T-Lymphocytes Expressing Herpes-Simplex Thymidine Kinase in Allogeneic Bone Marrow Transplantation: A Phase I–II Study. Laboratorie d'Histocompatibilité et Thérapeutique Immuno-Moléculaire, Besançon, France20 March 2008 | Human Gene Therapy, Vol. 8, No. 5Gene Therapy Approaches to Parkinson's Disease: Preclinical to Clinical Trials, or What Steps to Take to Get There from Here?Experimental Neurology, Vol. 144, No. 1Use of a Retroviral Vector to Study the Trafficking Patterns of Purified Ovarian Tumor Infiltrating Lymphocytes (TIL) Used in Intraperitoneal Adoptive Immunotherapy of Ovarian Cancer Patients. A Pilot Study. University of Texas M.D. Anderson Cancer Center, Houston, Texas20 March 2008 | Human Gene Therapy, Vol. 7, No. 11DNA Vectors Precedents and SafetyAnnals of the New York Academy of Sciences, Vol. 772, No. 1 DNA VaccinesOverview of Regulation of Gene Therapy in Europe: A Current Statement Including Reference to US Regulation19 March 2008 | Human Gene Therapy, Vol. 6, No. 6Cellular Gene TherapyHematology/Oncology Clinics of North America, Vol. 9, No. 1A Phase I Study of Autologous Bone Marrow Transplantation with Stem Cell Gene Marking in Multiple Myeloma. The Toronto Hospital, Ontario, Canada19 March 2008 | Human Gene Therapy, Vol. 6, No. 1Regulatory review of Cellular and Gene Therapies: An overview of the processTransfusion Science, Vol. 15, No. 4Regulation of gene therapy in Europe: a current statement including reference to US regulationEuropean Journal of Cancer, Vol. 30, No. 8 Volume 4Issue 5Oct 1993 InformationCopyright 1993, Mary Ann Liebert, Inc.To cite this article:Kurt C. Gunter, Arifa S. Khan, and Philip D. Noguchi.The Safety of Retroviral Vectors.Human Gene Therapy.Oct 1993.643-645.http://doi.org/10.1089/hum.1993.4.5-643Published in Volume: 4 Issue 5: March 19, 2008PDF download